SOTERA HEALTH COMPANY Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability
SOTERA HEALTH COMPANY (SHC) had Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability of $20.00 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability · last filed 2026-02-24
- SOTERA HEALTH COMPANY loss contingency, undiscounted amount of insurance-related assessment liability for the quarter ending 2024-03-31 was $20.00M, a 0.00% change year-over-year.
- SOTERA HEALTH COMPANY loss contingency, undiscounted amount of insurance-related assessment liability for the quarter ending 2023-12-31 was $0.00.
- SOTERA HEALTH COMPANY loss contingency, undiscounted amount of insurance-related assessment liability for the quarter ending 2023-09-30 was $0.00.
- SOTERA HEALTH COMPANY loss contingency, undiscounted amount of insurance-related assessment liability for the quarter ending 2023-06-30 was $0.00.
- SOTERA HEALTH COMPANY loss contingency, undiscounted amount of insurance-related assessment liability for fiscal 2023 was $20.00M, a 0.00% change from fiscal 2022.
- SOTERA HEALTH COMPANY loss contingency, undiscounted amount of insurance-related assessment liability for fiscal 2022 was $20.00M, a 0.00% change from fiscal 2021.
- SOTERA HEALTH COMPANY loss contingency, undiscounted amount of insurance-related assessment liability for fiscal 2021 was $20.00M.
| Period end | Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability | Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability 3 month | Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability 6 month | Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability 9 month | Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $20.00M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $20.00M 10-Q · filed 2025-11-04 | ||||
| 2025-06-30 | $20.00M 10-Q · filed 2025-08-08 | ||||
| 2025-03-31 | $20.00M 10-Q · filed 2025-05-01 | ||||
| 2024-12-31 | $20.00M 10-K · filed 2025-02-27 | ||||
| 2024-09-30 | $20.00M 10-Q · filed 2024-11-05 | ||||
| 2024-06-30 | $20.00M 10-Q · filed 2024-08-05 | ||||
| 2024-03-31 | $20.00M 10-Q · filed 2024-05-02 | $20.00M derived: sum of 2 quarters · filed 2024-05-02 | $20.00M derived: sum of 3 quarters · filed 2024-05-02 | $20.00M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $20.00M 10-K · filed 2024-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $20.00M 10-Q · filed 2023-11-01 | $20.00M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $20.00M 10-Q · filed 2023-08-03 | $20.00M derived: sum of 3 quarters · filed 2023-08-03 | $20.00M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2023-03-31 | $20.00M 10-Q · filed 2023-05-03 | $20.00M derived: sum of 2 quarters · filed 2023-05-03 | $20.00M derived: sum of 3 quarters · filed 2023-05-03 | $20.00M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $20.00M 10-K · filed 2023-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $20.00M 10-Q · filed 2022-11-02 | $20.00M derived: sum of 4 quarters · filed 2022-11-02 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $20.00M 10-Q · filed 2022-08-04 | $20.00M derived: sum of 3 quarters · filed 2022-08-04 | $20.00M derived: sum of 4 quarters · filed 2022-08-04 | |
| 2022-03-31 | $20.00M 10-Q · filed 2022-05-05 | $20.00M derived: sum of 2 quarters · filed 2022-05-05 | $20.00M derived: sum of 3 quarters · filed 2022-05-05 | $20.00M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $20.00M 10-K · filed 2022-03-01 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $20.00M 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $20.00M 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $20.00M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |